This compound is a PEGylated pharmaceutical intermediate featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a terminal carboxylic acid. It is primarily used in the synthesis of PEGylated compounds for research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
23-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,6,9,12,15,18,21-heptaoxatricosanoic acid
research compound
[2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid
pharmaceutical intermediate
5-(9-Fluorenylmethyloxycarbonylamino)-3-oxapentanoic acid
research compound
Fmoc-AEEA-AEEA
pharmaceutical intermediate
5-Bromo-2-(trifluoromethoxy)benzyl chloride
pharmaceutical intermediate
5-Acetyl-6-hydroxypicolinaldehyde
pharmaceutical intermediate
2-[(3R,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]ethanol
pharmaceutical intermediate
(3R,5R)-[2-[3,5-bis-(t-butyldimethyl-silanyloxy)-cyclohexylidene]-ethyl]-diphenyl-phosphine oxide
pharmaceutical intermediate
2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]acetic acid
XNOJSAOJCBOZTA-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCC(=O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.